APRICUS BIOSCIENCES INC Chart calendar Apricus Biosciences Inc
414f932d1bc68f93a.kLknU3GDqy8eSq2h1EmPVSTrKAvAxhmKoDfSX8yNHe4.9PNyBjnQ2VdMOMb2gw37J2Lef0SC8y_cyATnK5zYcbvKw0kkJe3mX2YZ6A~ddd458975eba767f24777d1b4d365764
Upcoming events on Apricus Biosciences Inc
Past events on Apricus Biosciences Inc
| 2024-04-25 | Q1 2024 Earnings Release (Projected) |
| 2024-01-10 08:00 am | Extraordinary Shareholders Meeting |
| 2023-11-13 09:00 am | Society for Neuroscience Meeting |
| 2023-09-20 08:00 am | SLS-002 Phase II Study Results Call |
| 2023-08-13 | Q2 2023 Earnings Release |
| 2023-07-18 01:00 pm | Investor Meeting - Key Opinion Leader |
| 2023-05-19 03:00 pm | American Society of Gene and Cell Therapy Meeting |
| 2023-05-17 | Annual General Meeting |
| 2023-05-15 08:00 am | Q1 2023 Earnings Release |
| 2023-03-05 | Cowen Health Care Conference |
| 2023-02-22 08:00 pm | Alzheimer & Parkinson Drug Development Summit |
| 2023-01-08 | LifeSci Partners Corporate Access Conference |
| 2022-12-15 01:00 pm | Business Update Call |
| 2022-11-15 01:35 pm | Guggenheim Immunology and Neurology Conference |
| 2022-11-03 05:45 pm | Ataxia Research International Congress |
| 2022-10-05 | Cantor Neurology & Psychiatry Conference |
| 2022-09-28 02:45 pm | Guggenheim Therapeutics Conference |
| 2022-09-21 | Jefferies Innovation in Mental Health Summit |
| 2022-06-10 11:30 am | Jefferies Healthcare Conference |
| 2022-05-20 08:00 am | Annual General Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,38 0,40 -6.25% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 2,20 1,55 42.13% |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -29,7 -23,9 -24.29% | -18,8 -17,2 -8.93% | -61,7 -45,1 -36.76% | -70,9 -68,6 -3.33% | -40,5 -39,5 -2.56% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -51,3 -45,0 -13.84% | -19,1 -16,9 -12.83% | -66,0 -49,6 -33.16% | -73,5 -70,2 -4.71% | -37,9 -39,4 3.9% |
|
Net income Million USD | Released Forecast Spread | -51,3 -45,0 -13.84% | -19,1 -16,9 -12.83% | -66,0 -49,6 -33.16% | -73,5 -70,2 -4.71% | -37,9 -39,4 3.9% |
|
EPS USD | Released Forecast Spread | -75,6 -98,9 23.52% | -12,9 -11,4 -13.16% | -21,9 -16,6 -32.33% | -20,7 -18,9 -9.52% | -7,73 -0,41 -1785.37% |
| Announcement Date | 17/03/20 | 11/03/21 | 04/03/22 | 10/03/23 | 06/03/24 |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,81 0,00 - | 0,34 0,00 - | 0,41 0,00 - | 0,65 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -27,4 -11,4 -139.15% | -14,0 -18,7 25.27% | -21,2 -15,4 -37.67% | -17,4 -12,5 -39.5% | -18,3 -16,0 -14.44% | -8,93 -13,3 32.81% | -11,0 -10,2 -7.09% | -12,6 -11,5 -9.22% | -8,01 -7,00 -14.44% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -27,3 -11,4 -138.49% | -14,0 -18,7 25.1% | -21,3 -15,4 -37.93% | -19,6 -12,5 -57.14% | -18,7 -16,0 -16.89% | -13,4 -13,2 -1.72% | -29,5 -10,3 -187.65% | 10,5 -11,5 191.12% | -5,45 -6,99 22.01% |
|
Net income Million USD | Released Forecast Spread | -27,3 -11,4 -138.49% | -14,0 -18,7 25.1% | -21,3 -15,4 -37.93% | -19,6 -12,5 -57.14% | -18,7 -16,0 -16.89% | -13,4 -13,2 -1.72% | -29,5 -10,3 -187.65% | 10,5 -11,5 191.12% | -5,45 -6,99 22.01% |
|
EPS USD | Released Forecast Spread | -8,40 -3,30 -154.55% | -3,90 -5,40 27.78% | -6,00 -4,30 -39.54% | -5,40 -3,40 -58.82% | -5,10 -3,90 -30.77% | -3,60 -3,20 -12.5% | -6,60 -2,85 -131.58% | 2,40 -1,80 233.33% | -0,80 |
| Announcement Date | 04/03/22 | 10/05/22 | 05/08/22 | 10/11/22 | 10/03/23 | 12/05/23 | 11/08/23 | 14/11/23 | 06/03/24 |
More events
